To check the effect and efficacy of an unani drug formulation in the management of gall bladder stone

A comparative study to validate the efficacy of unani compound drug in the management of cholelithiasis - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072721

Enrollment

Registered

2024-08-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K802- Calculus of gallbladder without cholecystitis

Interventions

Intervention1: Majoon Hajrul yahud: 7gms orally BD for 3 months Control Intervention1: Urdodeoxycholic acid: 300mg BD orally for 3 months

Eligibility

Inclusion criteria

Inclusion criteria: Cholelithiasis patients having symptoms and confirmed by USG Whole Abdomen. Patients of both the sexes in between the age group of 20 to 60 years. Patients with functioning gall bladder.

Exclusion criteria

Exclusion criteria: Choledocolithiasis. Non-functioning gall bladder Contracted gallbladder Shrinked gallbladder Thickened gallbladder Fibrosed gallbladder Mucocoele of gallbladder Pyocoele of gallbladder Jaundice Pediatric age group Stone size more than 15 mm Diabetes Mellitus Pregnancy and Lactation Mentally Retarded Patients

Design outcomes

Primary

Measure	Time frame
Improvement of subjective parameters. Reduction in the size or dissolution of stone as per USG.Timepoint: 3 months	—

Secondary

Measure	Time frame
Complete treatment of cholelithiasisTimepoint: 3 months	—

Countries

India

Contacts

Public ContactProf Abdul Quavi

State Takmeel ut Tib College and Hospital

quavinium@gmail.com9826212048

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026